What the Ozempic® and Rybelsus® decision really means for pharma strategy in 2026
What the Ozempic® and Rybelsus® decision really means for pharma strategy in 2026 Marcus Julius Zanon – Strategic IP &
Read More
What the Ozempic® and Rybelsus® decision really means for pharma strategy in 2026 Marcus Julius Zanon – Strategic IP &
Read MoreBrazil Establishes a Fully Regulated Cannabis Medicinal Framework — Strategic Implications for IP, Compliance and Market Entry TWS IP AI
Read More<!doctype html> TWS IP AI Tool – Brazil IP Intelligence Desk Decision-grade IP risk intelligence for partners &
Read MoreBrazil’s Health Authority Publishes Guidance on Monitoring International Health Regulation (IHR) Core Capacities at Designated Points of Entry Published: December
Read MoreANPD Prioritizes Children’s Data, AI, and Digital Governance Published: December 24, 2025 Brazil’s National Data Protection Authority (ANPD) has taken
Read More